PHIO Phio Pharmaceuticals Corp

Fundamentals / CIK 0001533040 / USD

Phio Pharmaceuticals Corp reported $11.32M in total assets and a net loss of $14.67M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PHIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$1.54M$770K$0-$12.44MFY 2016 Revenue: $19KFY 2016 Net Income: -$8.99M2016FY 2017 Revenue: $15KFY 2017 Net Income: -$12.45M2017FY 2018 Revenue: $138KFY 2018 Net Income: -$7.36M2018FY 2019 Revenue: $21KFY 2019 Net Income: -$8.91M2019FY 2020 Revenue: $0FY 2020 Net Income: -$8.79M2020FY 2021 Net Income: -$13.29M2021FY 2022 Net Income: -$11.48M2022FY 2023 Net Income: -$10.83M2023FY 2024 Net Income: -$7.15M2024FY 2025 Net Income: -$8.70M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- $0 $21K $138K $15K $19K
Research & Development $4.62M $3.64M $6.33M $7.01M $8.89M $3.72M $4.30M $4.33M $5.37M $5.42M
Total Operating Expenses $9.22M $7.39M $10.82M $11.46M $13.51M $8.79M $9.01M $7.50M $14.08M $9.03M
Operating Income -$9.22M -$7.39M -$10.82M -$11.46M -$13.51M -$8.79M -$8.99M -$7.36M -$14.06M -$9.02M
EBITDA -$9.22M -$7.38M -$10.77M -$11.39M -$13.44M -$8.72M -$8.92M -$7.28M -$13.99M -$8.96M
Income Before Tax -- -- -- -$11.48M -$13.29M -$8.79M -$8.91M -$7.36M -$14.07M -$8.99M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 -$1.62M $0
Net Income -$8.70M -$7.15M -$10.83M -$11.48M -$13.29M -$8.79M -$8.91M -$7.36M -$12.45M -$8.99M
Basic EPS -$1.45 -$9.08 -$46.76 -$90.91 -$1,343.11 -$207.46 -$2,088.68 -$341,141.99 -$32,772.43 -$97,426.73
Diluted EPS -- -$9.08 -$46.76 -$90.91 -$1,343.11 -$207.46 -$2,088.68 -$341,141.99 -$32,772.43 -$97,426.73
Basic Shares Outstanding 6.0M 787.5K 231.5K 126.3K 9.9K 42.5K 4.3K 22 380 114
Diluted Shares Outstanding -- 787.5K 231.5K 126.3K 9.9K 42.5K 4.3K 22 380 114

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $3.06M $3.08M $2.79M $1.48M $1.18M $1.07M $886K $985K
Total Operating Expenses $4.27M $4.27M $4.17M $2.53M $2.50M $2.31M $1.87M $1.67M
Operating Income -$4.27M -$4.27M -$4.17M -$2.53M -$2.50M -$2.31M -$1.87M -$1.67M
EBITDA -$4.27M -$4.27M -$4.17M -$2.53M -$2.50M -$2.31M -$1.87M -$1.67M
Interest Expense -- -- -- -- -- -- -$125K --
Net Income -$4.16M -$4.14M -$4.00M -$2.37M -$2.39M -$2.17M -$1.77M -$1.63M
Basic EPS -$0.36 -$0.36 -$0.34 -- -$0.44 -$0.45 -$0.41 --
Diluted EPS -- -- -- -- -- -$0.45 -$0.41 --
Basic Shares Outstanding 11.7M 11.6M 11.6M -- 5.5M 4.8M 4.3M --
Diluted Shares Outstanding -- -- -- -- -- 4.8M 4.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $21.03M $5.38M $8.49M $11.78M $24.06M $14.24M $6.93M $14.88M $3.58M $12.91M
Cash & Short-Term Investments $21.03M $5.38M $8.49M $11.78M $24.06M $14.24M $6.93M $14.88M $3.58M $12.91M
Total Current Assets $21.48M $5.74M $9.32M $12.45M $24.73M $15.16M $7.30M $15.15M $3.83M $13.11M
Property, Plant & Equipment, Net $11K $2.0K $6.0K $183K $133K $157K $210K $172K $248K $114K
Other Non-Current Assets -- $0 $3.0K $24K $27K $18K $18K $0 $18K $27K
Total Non-Current Assets $11K $2.0K $42K $368K $443K $575K $739K $172K $266K $291K
Total Assets $21.49M $5.74M $9.36M $12.81M $25.17M $15.74M $8.04M $15.32M $4.10M $13.40M
Accounts Payable $435K $253K $657K $779K $283K $728K $809K $550K $511K $917K
Total Current Liabilities -- $1.01M $1.63M $1.94M $3.07M $2.20M $1.88M $1.74M $2.27M $2.54M
Long-Term Debt -- -- -- -- $0 $231K $0 -- -- --
Total Non-Current Liabilities -- $0 $0 $35K $170K $526K $411K $0 $0 $0
Total Liabilities $1.34M $1.01M $1.63M $1.97M $3.24M $2.72M $2.29M $1.74M $2.27M $2.54M
Total Debt (incl. Leases) -- -- $35K $170K $295K $642K $518K -- -- --
Common Stock $1.0K $0 $0 $0 $0 $1.0K $1.0K $0 $0 $0
Retained Earnings -$155.1M -$146.4M -$139.2M -$128.4M -$116.9M -$103.6M -$94.82M -$85.91M -$78.55M -$66.10M
Total Stockholders' Equity $20.15M $4.72M $7.73M $10.84M $21.93M $13.02M $5.75M $13.58M $1.83M $10.86M
Total Equity $20.15M $4.72M $7.73M $10.84M $21.93M $13.02M $5.75M $13.58M $1.83M $10.86M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $10.61M $13.00M $17.03M $21.03M $10.71M $10.78M $13.28M $5.38M
Cash & Short-Term Investments $10.61M $13.00M $17.03M $21.03M $10.71M $10.78M $13.28M $5.38M
Total Current Assets $11.31M $14.30M $17.40M $21.48M $11.49M $11.29M $13.44M $5.74M
Property, Plant & Equipment, Net $7.0K $9.0K $10K $11K $12K $7.0K $4.0K $2.0K
Other Non-Current Assets -- -- -- -- -- -- -- $0
Total Non-Current Assets $7.0K $9.0K $10K $11K $12K $7.0K $4.0K $2.0K
Total Assets $11.32M $14.31M $17.41M $21.49M $11.51M $11.30M $13.44M $5.74M
Accounts Payable $886K $901K $260K $435K $516K $235K $427K $253K
Total Current Liabilities -- -- -- -- -- $1.21M $1.27M $1.01M
Total Non-Current Liabilities -- -- -- -- -- $0 $0 $0
Total Liabilities $2.70M $1.71M $950K $1.34M $1.67M $1.21M $1.27M $1.01M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $0 $0 $0
Retained Earnings -$167.4M -$163.2M -$159.1M -$155.1M -$152.7M -$150.3M -$148.1M -$146.4M
Total Stockholders' Equity $8.62M $12.60M $16.46M $20.15M $9.84M $10.10M $12.17M $4.72M
Total Equity $8.62M $12.60M $16.46M $20.15M $9.84M $10.10M $12.17M $4.72M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$8.70M -$7.15M -$10.83M -$11.48M -$13.29M -$8.79M -$8.91M -$7.36M -$12.45M -$8.99M
Depreciation & Amortization $3.0K $2.0K $56K $71K $75K $72K $67K $81K $70K $53K
Stock-Based Compensation $481K $147K $303K $414K $480K $136K $300K $282K $314K $756K
Change in Payables $183K -$404K -$122K $496K -$445K -$81K $259K $39K -$608K -$246K
Operating Cash Flow -$7.98M -$7.11M -$10.75M -$12.13M -$11.86M -$8.80M -$8.64M -$7.52M -$9.51M -$7.76M
Capital Expenditure -$12K -$1.0K -$5.0K -$121K -$51K -$19K -$72K -$5.0K -$203K -$4.0K
Free Cash Flow -$7.99M -$7.11M -$10.75M -$12.25M -$11.91M -$8.82M -$8.72M -$7.53M -$9.72M -$7.76M
Sales & Maturities of Investments -- -- -- -- -- -- -- -- -- $7.50M
Investing Cash Flow -$12K $8.0K -$5.0K -$121K -$51K -$19K -$72K -$5.0K -$103K $5.35M
Common Stock Issued $20.60M $4.00M $7.45M -- -- $12.09M $708K $1.31M $290K $10.20M
Financing Cash Flow $23.64M $4.00M $7.41M -$26K $21.72M $16.13M $772K $18.82M $292K $10.20M
Net Change in Cash $15.65M -$3.11M -$3.34M -$12.28M $9.81M $7.31M -$7.95M $11.30M -$9.32M $7.79M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.16M -$4.14M -$4.00M -$2.37M -$2.39M -$2.17M -$1.77M -$1.63M
Depreciation & Amortization $2.0K $1.0K $1.0K $1.0K $2.0K $0 $0 $0
Stock-Based Compensation $285K $278K $318K $274K $113K $51K $43K $48K
Change in Payables -$15K $641K -$175K -$80K $281K -$192K $174K $69K
Operating Cash Flow -$2.28M -$4.04M -$4.00M -$2.08M -$2.08M -$2.54M -$1.27M -$1.37M
Capital Expenditure $0 $0 $0 $0 -$7.0K -$3.0K -$2.0K -$1.0K
Free Cash Flow -$2.28M -$4.04M -$4.00M -$2.08M -$2.09M -$2.54M -$1.28M -$1.37M
Investing Cash Flow $0 $0 $3.0K $0 -$7.0K -$3.0K -$2.0K $8.0K
Financing Cash Flow -$107K $0 $0 $12.40M $2.02M $40K $9.17M $1.35M
Net Change in Cash -$2.39M -$4.04M -$4.00M $10.33M -$70K -$2.50M $7.90M -$8.0K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -- -42795.2% -5336.2% -93746.7% -47447.4%
Net Profit Margin -- -- -- -- -- -- -42419.0% -5333.3% -83013.3% -47336.8%
Return on Equity (ROE) -43.2% -151.4% -140.1% -105.9% -60.6% -67.6% -155.0% -54.2% -679.3% -82.9%
Return on Assets (ROA) -40.5% -124.6% -115.6% -89.6% -52.8% -55.9% -110.8% -48.0% -303.9% -67.1%
Current Ratio -- 5.65x 5.71x 6.42x 8.06x 6.91x 3.88x 8.69x 1.69x 5.16x
Quick Ratio -- 5.30x 5.20x 6.08x 7.84x 6.49x 3.69x 8.53x 1.58x 5.08x
Debt to Equity -- -- 0.00x 0.02x 0.01x 0.05x 0.09x -- -- --
Revenue Growth (YoY) -- -- -- -- -- -100.0% -84.8% +820.0% -21.1% -44.1%
5Y Revenue / Share Growth -- -- -- -- -- -100.0% -- +172.0% -96.9% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -170.2% -102.4% -66.4% -43.2% -80.8% -70.2% -55.6% -151.4%
Return on Assets (ROA) -129.6% -90.2% -62.8% -40.5% -69.1% -62.7% -50.3% -124.6%
Current Ratio -- -- -- -- -- 9.36x 10.58x 5.65x
Quick Ratio -- -- -- -- -- 8.93x 10.46x 5.30x
Source: SEC EDGAR CompanyFacts (CIK 0001533040) · from December 31, 2003 Data through September 30, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal